Oura, the Finnish smart ring maker, has filed for an initial public offering, positioning itself to enter public markets after years of private fundraising and consumer traction. The company cited significant revenue growth over the past year as a driver for the IPO decision.

Oura manufactures the Oura Ring, a wearable device that tracks sleep, activity, heart rate variability, and other health metrics. Users pay an upfront hardware cost between $299 and $599 depending on the model, plus a $5.99 monthly subscription for the Oura app and premium analytics. The company competes against Whoop, a subscription-based fitness tracker, as well as traditional smartwatch makers like Apple, Garmin, and Samsung that offer overlapping health-tracking capabilities.

The company has raised over $200 million in venture funding to date. Previous investors include prominent VC firms such as Khosla Ventures, Founders Fund, and Tiger Global. Oura's valuation reached approximately $2.6 billion in its last private funding round in 2022, according to private market databases. The IPO filing represents an exit opportunity for these early investors while allowing Oura to access public capital markets for growth and R&D investments.

Oura's business model centers on recurring revenue through its subscription service, which appeals to health-conscious consumers and athletes. The company expanded beyond direct-to-consumer sales into partnerships with health systems and employers seeking to provide employees with biometric data for wellness programs. This B2B channel diversification strengthens its growth narrative heading into public markets.

The smart ring category itself remains nascent compared to smartwatches and fitness trackers. Oura holds the dominant market position in the space, though Samsung launched the Galaxy Ring in 2024 with significant marketing resources behind it. That competitive threat makes Oura's IPO timing strategic. Going public provides capital to accelerate product development, international expansion, and marketing spend to defend market position against well-capitalized rivals.

Oura's filing also arrives during a period of renewed investor appetite for health tech companies that demonstrate clear unit economics and subscription retention metrics. The company's emphasis on revenue growth signals strong customer acquisition and retention, which public markets reward for SaaS and subscription-based businesses.

The IPO process typically takes several months from filing to listing. Oura will need to complete SEC review, roadshow investor presentations, and price discovery before trading begins. The company has not yet announced a target listing date or estimated valuation range, though market conditions and investor demand will shape final pricing.

This move represents a significant validation of the smart ring category and Oura's ability to build a sustainable, profitable business in wearable health technology. Success in public markets could attract additional venture capital into competing ring makers and similar biometric wearables, further establishing this hardware category as a legitimate alternative to smartphones for health tracking.